Oncos Molbiol Limited

Shout out to my newest followers! Excited to have you onboard! Ehsan Rahim, Asif Shahriar

We are proud to announce the signing of our latest Memorandum of Understanding (MoU) has been signed between Oncos Molbiol Limited& Arogga - আরোগ্য.
The MoU, which has been signed today 19th October at Arogga office with senior representatives from both companies. This MoU is considered an important step for digital health service towards enhancing all kinds of Pathological home services for mass peoples of our country. Furthermore, considering the historical ties and common interests between the two organizations, a bilateral cooperation platform with the arogga is of particular value.

Germany & America এর পরেই Oncos Molbiol launch করলো immune cell quantification ( i mune TBNK and i mune Neo).

বাংলাদেশে নতুন উদ্ভাবিত ডায়গনিস্টিক পরীক্ষার সফল যাত্রা শুরু! বাংলাদেশে নতুন উদ্ভাবিত i.mune TBNK এবং i.mune Neo-এর ডায়গনিস্টিক পরীক্ষার উচ্চ-প্রত্যাশিত লঞ্চিং সফলভাবে সম্পন্ন হয়েছে। Oncos ...

Thrilled to Announce the Successful Launch of i.mune TBNK & i.mune Neo in Bangladesh

We're elated to unveil that the highly-anticipated launch of i.mune TBNK and i.mune Neo in Bangladesh was an astounding success! This joint initiative between Oncos Molbiol, Radiant Business Consortium Limited, and Epimune Diagnostics, Germany, sets a new benchmark in the world of diagnostics.

Spanning two action-packed days, the event was held at The Westin on September 8th and Hotel Intercontinental on September 9th, 2023.

Nearly 400 healthcare luminaries across specialties came together to discuss and celebrate groundbreaking innovations in diagnostics.

Our distinguished lineup of speakers were:
Staub, CEO of Epimune GmbH, Germany
Landt, CEO of Tib Mol Biol lab
Prof. M. Sawkat Hassan, Director, Laboratory Science Division, BIRDEM General Hospital
Dr. Sohrab Alam, Director, Oncos Molbiol Ltd

Mr. Md. Abu Shahriar Zahedee, MD of Oncos Molbiol and Executive Director of Radiant Pharmaceuticals Limited, played an instrumental role in orchestrating the event.
Lt. Gen. Sina Ibn Jamali (Retd), MD of Radiant Pharmaceuticals Limited, graced the occasion with his esteemed presence.
Our Chairman, Mr. Nasser Shahrear Zahedee, a celebrated philanthropist and a towering figure in the pharma sector, inspired everyone with his motivational address.

This milestone propels us further in our relentless pursuit of excellence in diagnostics. We're excited for what lies ahead as we continue our mission to transform healthcare and elevate lives.

উত্তরা এবং আশে পাশের সকল শুভানুধ্যায়ীদের জন্য এক সূবর্ণ সুযোগ। ফ্রি মেডিকেল ক্যাম্পে সকলের অংশগ্রহণ কামনা করছি ।

Early Detection Save Life

Oncos Molbiol Limited has signed MOU with Shastho AI today. Honorable Managing Director of ONCOS Molbiol limited & CEO of Shastho AI has signed the agreement.

Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine. In personalized medicine, diagnostic analysis is often conducted for selecting suitable and best treatments based on the patient’s genetic content or other molecular or cellular analysis. Personalized medicine has best response and highest safety margin to ensure enhanced patient care by allowing every patient to attain earlier diagnosis, risk assessment, and best treatment. Additionally, personalized medicine offers opportunities to improve health care by lowering overall treatment costs.

Cancer is a serious disease, but it is often preventable and treatable if detected early. That's why it's so important to be aware of the signs and symptoms of cancer, and to get regular screenings if you are at risk.
The most common signs and symptoms of cancer:

1- A lump or mass
Unexplained weight loss
2- Changes in bowel or bladder habits
3- Persistent cough or hoarseness
4- Unexplained bleeding or discharge
5- Sore that does not heal
6- Changes in skin such as moles or freckles 7- A lump or mass
8- Unexplained weight loss
9- Changes in bowel or bladder habits
10- Persistent cough or hoarseness
11- Unexplained bleeding or discharge
12-Sore that does not h&eal
13 Changes in skin such as moles or freckles

Oncos Molbiol Limited is providing Comprehensive Genomic Profiling service with the collaboration of Roche FMI (USA). It's a great opportunity for the physician to serve the cancer patients with personalized medicine as WHO guidelines.

Interested candidates are requested to send your CV to [email protected]

Sahri and Iftar time for the 10 days of Maghfirah.

Oncos Molbiol Limited (OML) is one of the fastest-growing diagnostics service providers having its home sample collection services. We provide preventive health tests with special tests at the most honest prices.